Drug-eluting Balloons Equivalent to Drug-Eluting Stents in Terms of Safety for Managing Coronary Artery Disease
Drug-elutingBalloon (DEB), also referred to as drug-coated balloon (DCB), is used to release anti-proliferative drugs into the vessel wall during inflation of the balloon, usually at nominal pressures with a specific minimal inflation time. These semi-compliant angioplasty balloons are typically used in re-stenotic lesions, which are previously stented segments that have developed neointimal hyperplasia and luminal loss. There are four key components to a DEB. These include, the balloon platform, the drug, an excipient to hold the drug on the balloon and control its release, and the balloon coating process. The transcatheter technology in drug-eluting balloons helps to reduce high restenosis rates in peripheral artery disease (PAD). The global prevalence of PAD in people aged 25 years and older was 5·56%, according to a study, published in The Lancet in August 2019. The study took into account national prevalence data of PAD from Bangladesh, Brazil, China, France, G...